
Quinazoline and Quinoline Derivatives
Quinazolines and quinolines are nitrogen-containing heterocyclic compounds with aromatic structures that play a key role in the synthesis of drugs with anticancer, antimicrobial, and anti-inflammatory activity. Their derivatives feature structural modifications that optimise bioavailability and selectivity, enabling the development of new active ingredients for various therapeutic applications. These compounds are used in the manufacture of APIs for the treatment of cancer, infections, neurodegenerative diseases, and cardiovascular conditions. Additionally, quinazoline and quinoline derivatives are essential in the research of enzyme inhibitors and the design of innovative bioactive molecules.
At CymitQuimica, we offer high-purity quinazoline and quinoline derivatives for applications in chemical synthesis, pharmaceutical development, and biotechnology.
Found 65580 products of "Quinazoline and Quinoline Derivatives"
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Rivaroxaban Related Compound G ((S)-2-({2-oxo-3-[4-(3-oxomorpholino)phenyl]oxazolidin-5-yl}methyl)isoindoline-1,3-dione)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C22H19N3O6Color and Shape:White Off-White SolidMolecular weight:421.12739Dabigatran Etexilate Related Compound C (Ethyl 3-(2-{[(4-{N'-[(2-ethylbutoxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-N-(pyridin-2-yl)-1H-benzimidazole-5-carboxamido)propanoate)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C34H41N7O5Color and Shape:PowderMolecular weight:627.31692Carbamazepine Dione (10,11-dioxo-10,11-dihydro-5H-dibenzo[b,f]azepine-5-carboxamide)
CAS:Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormula:C15H10N2O3Color and Shape:Greenish-Yellow SolidMolecular weight:266.06914Bis((R)-butyramide) ((R)-2-amino-N-((R)-1-amino-1-oxobutan-2-yl)butanamide)
CAS:Acyclic amides (including acyclic carbamates) and their derivatives and salts thereof, nesoiFormula:C8H17N3O2Color and Shape:White Off-White PowderMolecular weight:187.13208Atazanavir System Suitability Mixture (A mixture of atazanavir sulfate, atazanavir R, S, S, S,-diastereomer and atazanavir S,R,S,S diastereomer)
Compounds containing an unfused pyridine ring in the structure, nesoiColor and Shape:White Light Yellow Crystalline PowderSunitinib Amide (5-[(Z)-(5-Fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide)
CAS:Lactams, nesoiFormula:C16H14FN3O2Color and Shape:Pale Yellow Yellow PowderMolecular weight:299.107Clioquinol
CAS:Drugs containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fusedFormula:C9H5ClINOColor and Shape:PowderMolecular weight:304.91044Apixaban Related Compound F (Ethyl 1-(4-methoxyphenyl)-6-(4-nitrophenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate)
CAS:Lactams, nesoiFormula:C22H20N4O6Color and Shape:Light Brown PowderMolecular weight:436.13828Ambrisentan Related Compound A (4,6-Dimethyl-2-(methylsulfonyl)pyrimidine)
CAS:Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormula:C7H10N2O2SColor and Shape:Off-White Light Brown Crystalline PowderMolecular weight:186.0463Bicalutamide Related Compound A (N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluoro-phenyl)sulfinyl]-2-hydroxy-2-methyl-propanamide)
Other aromatic organo-sulfur compounds (excluding pesticides)Color and Shape:PowderMolecular weight:414.384-Chloro Omeprazole (2-[(RS)-[4-Chloro-3,5-dimethylpyridin-2-yl)methyl]sulfinyl]-5-methoxy-1H-benzimidazole)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C16H16ClN3O2SColor and Shape:Off-White SolidMolecular weight:349.06518Rivaroxaban
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C19H18ClN3O5SColor and Shape:White PowderMolecular weight:435.06557Leflunomide Tolyl Analog (5-Methyl-N-(4-methylphenyl)-4-isoxazolecarboxamide)
CAS:Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormula:C12H12N2O2Color and Shape:White PowderMolecular weight:216.08988Sorafenib Diarylurea Analog (4,4'-[carbonylbis(azanediyl-4,1-phenyleneoxy)]bis(N-methylpyridine-2-carboxamide);N,N'-Bis{4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl}urea)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C27H24N6O5Color and Shape:White Off-White SolidMolecular weight:512.18082Aripiprazole
CAS:Lactams, nesoiFormula:C23H27Cl2N3O2Color and Shape:White Pale Yellow PowderMolecular weight:447.14803Clozapine
CAS:Drugs containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormula:C18H19ClN4Color and Shape:Yellow PowderMolecular weight:326.12982Sorafenib Related Compound H (4-(4-{3-[2-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N-methylpicolinamide)
CAS:Compounds containing an unfused pyridine ring in the structure, nesoiFormula:C21H16ClF3N4O3Color and Shape:Pale Yellow SolidMolecular weight:464.0863Levetiracetam Crotonamide ((Z)-2-(2-oxopyrrolidin-1-yl)but-2-enamide)
CAS:Lactams, nesoiFormula:C8H12N2O2Color and Shape:White Off-White SolidMolecular weight:168.08988Butylated Hydroxytoluene
CAS:Monophenols, nesoiFormula:C15H24OColor and Shape:White PowderMolecular weight:220.18272Benzyl Alcohol
CAS:Benzyl alcohol (alpha-hydroxytoluene; phenyl-methanol)Formula:C7H8OColor and Shape:Colorless Clear LiquidMolecular weight:108.14 g/mol

